ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) HKSE

15.00

+1.02(+7.30%)

Updated at September 08 04:08PM

Currency In HKD

Valuation

Market Cap1.83B
Enterprise Value1.49B
P/E Ratio-16.37
PEG Ratio-0.58
Price/Sales Ratio67.78
Price/Book Ratio7.62
Enterprise/Revenue63.48
Enterprise/EBITDA-17.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-3.97
Operating Margin-3.87

Management Effectiveness

Return On Assets-0.34
Return On Equity-0.49

Income Statement

Revenue74.15M
Revenue/Share0.21
Gross Profit74.15M
EBITDA-295.63M
Net Income-315.86M
Diluted EPS-0.84

Balance Sheet

Total Cash752.12M
Total Cash/Share1.98
Total Debt136.36M
Total Debt/Equity0.2
Current Ratio4.04
Book Value Per Share1.78

Price History

52-Week Change318.87
52-Week High15.68
52-Week Low3.21
Moving Average 50 Days11.43
Moving Average 200 Days8

Statistics

Average Volume3.88M
Shares Outstanding396.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A